PTIX logo

Protagenic Therapeutics (PTIX)

Profile

Full Name

Protagenic Therapeutics, Inc.

Ticker Symbol

PTIX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

April 27, 2021

Indexes

Not included

Website

http://www.protagenic.com

Employees

1

Key Details

Price

$0.31(+3.00%)

Market cap

Last Dividend

$34.27M

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$1.13(+1.74% YoY)

PE ratio

-

Next earnings date

May 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.31
PTIX price is $0.31

30-Day Relative Volume

0.02
PTIX 30-day relative volume is 0.02

Price Performance

Price Most recent change

+3%
PTIX price was up +3% on Apr 14, 2025

Price YTD change

-36.94%
PTIX price is down -36.94% since January 1st

Price 1-year change

-78.54%
PTIX price is down -78.54% year-on-year

Price 3-year change

-90.69%
PTIX price is down -90.69% over the past 3 years

Price Range

Price All-time high

$19.56
PTIX price is currently -98.42% below its historical high of $19.56

Price 3-year low

$0.18
PTIX price is currently +72.63% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$2.33M
PTIX market capitalization is $2.33 million

Market cap 3-year change

-83.76%
PTIX market capitalization is down -83.76% over the past 3 years

Market cap All-time high

$49.35M
PTIX market capitalization is currently -95.29% below its historical high of $49.35 million

Market cap sector rank

7.4%
PTIX market capitalization is higher than 7.4% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+69.69%
PTIX shares outstanding is up +69.69% year-on-year

Shares Outstanding 3-Year Change

+74.48%
PTIX shares outstanding is up +74.48% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

-1.10
PTIX beta is -1.10

200-day SMA

$0.54
PTIX price is currently -42.72% below its 200-day simple moving average

50-day SMA

$0.28
PTIX price is currently +8.88% above its 50-day simple moving average

RSI

51.29
PTIX 14-day relative strength index is 51.29

Volume

0.02
PTIX 30-day relative volume is 0.02

ATR

$0.07
PTIX average true range is $0.07

10-day Historical Volatility

480.36%
PTIX 10-day historical volatility is 480.36%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$34.27 million
PTIX last dividend was $34.27 million per share, with an ex-dividend date of December 5, 2005

Next Dividend

-
PTIX next dividend has not yet been announced

Dividend per share

Dividend per share

-
PTIX annual dividend per share value is unknown

Dividend per share Sector Rank

-
PTIX annual dividend per share is unknown

Dividend per share 1-Year Change

-
PTIX annual dividend per share 1-year change is unknown

Dividend per share 3-Year Change

-
PTIX annual dividend per share 3-year change is unknown

Dividend yield

Dividend yield

-
PTIX annual dividend yield value is unknown

Dividend yield Sector Rank

-
PTIX annual dividend yield is unknown

Other

Payout ratio

-
PTIX annual payout ratio value is unknown

Dividends paid

-
PTIX annual dividends paid value is unknown

Free cash flow

-$4.22M
PTIX annual free cash flow is -$4.22 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
PTIX annual revenue value is unknown

Revenue Analysts estimate

-
PTIX annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
PTIX annual revenue 1-year change is unknown

Revenue Sector rank

-
PTIX annual revenue is unknown

EPS

EPS

-$1.13
PTIX annual earnings per share is -$1.13

EPS Analysts estimate

-
PTIX annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

+1.74%
PTIX annual earnings per share is up +1.74% year-on-year

EPS Sector rank

53.92%
PTIX annual earnings per share is higher than 53.92% of companies in Healthcare sector

Profit

Gross profit

-
PTIX annual gross profit value is unknown

Gross margin

-
PTIX annual gross profit margin value is unknown

Operating profit

-$5.70M
PTIX annual operating income is -$5.70 million

Operating margin

-
PTIX annual operating profit margin value is unknown

Net income

-$5.53M
PTIX annual net profit is -$5.53 million

Net margin

-
PTIX annual net profit margin value is unknown

Expenses

Total expenses

$5.70M
PTIX annual total expenses is $5.70 million

Operating expenses

$5.70M
PTIX annual total operating expenses is $5.70 million

Cost of goods sold

-
PTIX annual cost of goods sold value is unknown

Selling, general & administrative expenses

$1.76M
PTIX annual SGA is $1.76 million

Depreciation and amortization

$50.30K
PTIX annual depreciation & amortization is $50.30 thousand

Interest expense

$0.00
PTIX annual interest expense is $0.00

Income tax

$0.00
PTIX annual income tax is $0.00

EBIT & EBITDA

EBIT

-$5.53M
PTIX annual earnings before interest & taxes is -$5.53 million

EBITDA

-$5.48M
PTIX annual EBITDA is -$5.48 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$1.96M
PTIX annual total assets is $1.96 million

Non current assets

$73.00K
PTIX annual long term assets is $73.00 thousand

Current assets

$1.88M
PTIX annual total current assets is $1.88 million

Cash and cash equivalents

$1.84M
PTIX annual cash & cash equivalents is $1.84 million

Accounts receivable

-
PTIX annual accounts receivable value is unknown

Inventory

-
PTIX annual inventory value is unknown

Liabilities

Total liabilities

$942.80K
PTIX annual total liabilities is $942.80 thousand

Long term liabilities

$0.00
PTIX annual total long term liabilities is $0.00

Current liabilities

$942.80K
PTIX annual total current liabilities is $942.80 thousand

Accounts payable

$103.00K
PTIX annual accounts payable is $103.00 thousand

Debt

Total debt

$0.00
PTIX annual total debt is $0.00

Total debt 1-year change

0%
PTIX {parameterFullLabel} has remained unchanged year-on-year

Long term debt

-
PTIX annual long term debt value is unknown

Short term debt

-
PTIX annual short term debt value is unknown

Equity & Capital

Shareholders equity

$1.01M
PTIX annual stockholders equity is $1.01 million

Book value

$1.01M
PTIX annual book value is $1.01 million

Retained earnings

-$36.30M
PTIX annual retained earnings is -$36.30 million

Working capital

$940.10K
PTIX annual working capital is $940.10 thousand

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$4.22M
PTIX annual cash flow from operations is -$4.22 million

Cash from operations 1-year change

-13.84%
PTIX annual cash flow from operations is down -13.84% year-on-year

Cash from investing

$2.80M
PTIX annual cash flow from investing activities is $2.80 million

Cash from investing 1-year change

-41.31%
PTIX annual cash flow from investing activities is down -41.31% year-on-year

Cash from financing

$1.96M
PTIX annual cash flow from financing activities is $1.96 million

Cash from financing 1-year change

+100%
PTIX annual cash flow from financing activities is up +100% year-on-year

CAPEX

CAPEX

-
PTIX annual capital expenditures value is unknown

CAPEX 1-year change

-
PTIX annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$4.22M
PTIX annual free cash flow is -$4.22 million

Free cash flow 1-year change

-9.42%
PTIX annual free cash flow is down -9.42% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
PTIX annual gross profit margin value is unknown

Operating margin

-
PTIX annual operating profit margin value is unknown

Net margin

-
PTIX annual net profit margin value is unknown

ROA & ROE

ROA

-282.49%
PTIX annual return on assets is -282.49%

ROE

-545.33%
PTIX annual return on equity is -545.33%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
PTIX price to earnings ratio value is unknown

PE ratio Sector rank

-
PTIX price to earnings ratio is unknown

PB Ratio

PB ratio

2.30
PTIX price to book ratio is 2.30

PB ratio Sector rank

66.37%
PTIX price to book ratio is higher than 66.37% of companies in Healthcare sector

PS Ratio

PS ratio

-
PTIX price to sales ratio value is unknown

PS ratio Sector rank

-
PTIX price to sales ratio is unknown

Enterprise value

Enterprise value

$486.94K
PTIX enterprise value is $486.94 thousand

Enterprise value Sector rank

12.63%
PTIX enterprise value is higher than 12.63% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.09
PTIX EV/EBITDA is -0.09

EV/EBITDA Sector rank

61.86%
PTIX EV/EBITDA is higher than 61.86% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.00
PTIX annual current ratio is 2.00

Quick ratio

-
PTIX annual quick ratio value is unknown

Leverage

Debt to equity

0.00
PTIX annual debt to equity ratio is 0.00

Interest coverage ratio

-
PTIX annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
PTIX piotroski f-score value is unknown

Altman Z-Score

-
PTIX altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Oct 29, 21 Maxim Group
Buy

Institutional Ownership

Similar stocks

Syra Health Corp Class A (SYRA)
SQL logo
SeqLL (SQL)
BBLG logo
Bone Biologics (BBLG)
QLGN logo
Qualigen Therapeutics (QLGN)
OMGA logo
Omega Therapeutics (OMGA)
GCTK logo
GlucoTrack (GCTK)
ENVB logo
Enveric Biosciences (ENVB)
VERO logo
Venus Concept (VERO)
THAR logo
Tharimmune (THAR)
  • What is the ticker symbol for Protagenic Therapeutics?
  • Does Protagenic Therapeutics pay dividends?
  • What sector is Protagenic Therapeutics in?
  • What industry is Protagenic Therapeutics in?
  • What country is Protagenic Therapeutics based in?
  • When did Protagenic Therapeutics go public?
  • Is Protagenic Therapeutics in the S&P 500?
  • Is Protagenic Therapeutics in the NASDAQ 100?
  • Is Protagenic Therapeutics in the Dow Jones?
  • When was Protagenic Therapeutics's last earnings report?
  • When does Protagenic Therapeutics report earnings?
  • Should I buy Protagenic Therapeutics stock now?

What is the ticker symbol for Protagenic Therapeutics?

The ticker symbol for Protagenic Therapeutics is NASDAQ:PTIX

Does Protagenic Therapeutics pay dividends?

No, Protagenic Therapeutics does not pay dividends

What sector is Protagenic Therapeutics in?

Protagenic Therapeutics is in the Healthcare sector

What industry is Protagenic Therapeutics in?

Protagenic Therapeutics is in the Biotechnology industry

What country is Protagenic Therapeutics based in?

Protagenic Therapeutics is headquartered in United States

When did Protagenic Therapeutics go public?

Protagenic Therapeutics's initial public offering (IPO) was on April 27, 2021

Is Protagenic Therapeutics in the S&P 500?

No, Protagenic Therapeutics is not included in the S&P 500 index

Is Protagenic Therapeutics in the NASDAQ 100?

No, Protagenic Therapeutics is not included in the NASDAQ 100 index

Is Protagenic Therapeutics in the Dow Jones?

No, Protagenic Therapeutics is not included in the Dow Jones index

When was Protagenic Therapeutics's last earnings report?

Protagenic Therapeutics's most recent earnings report was on Nov 14, 2024

When does Protagenic Therapeutics report earnings?

The next expected earnings date for Protagenic Therapeutics is May 15, 2025

Should I buy Protagenic Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page